rs121908325
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_015627.3(LDLRAP1):c.406C>T(p.Gln136*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,074 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015627.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LDLRAP1 | NM_015627.3 | c.406C>T | p.Gln136* | stop_gained | Exon 4 of 9 | ENST00000374338.5 | NP_056442.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LDLRAP1 | ENST00000374338.5 | c.406C>T | p.Gln136* | stop_gained | Exon 4 of 9 | 1 | NM_015627.3 | ENSP00000363458.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461882Hom.: 1 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727248 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 4 Pathogenic:4
This sequence change creates a premature translational stop signal (p.Gln136*) in the LDLRAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLRAP1 are known to be pathogenic (PMID: 11326085, 12464675). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with familial hypercholesterolemia (PMID: 11326085, 27247956). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4775). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
Cardiovascular phenotype Pathogenic:1
The p.Q136* pathogenic mutation (also known as c.406C>T), located in coding exon 4 of the LDLRAP1 gene, results from a C to T substitution at nucleotide position 406. This changes the amino acid from a glutamine to a stop codon within coding exon 4. This alteration has been described in homozygous state in families with familial hypercholesterolemia (Garcia CK et al. Science, 2001 May;292:1394-8; Soufi M et al. Gene, 2013 May;521:200-3; Fahed AC et al. Mol Genet Genomic Med, 2016 May;4:283-91). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Familial hypercholesterolemia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at